Welcome
Support Centre
10 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effects of exercise on knee cartilage and bone
ISRCTN ISRCTN58314639
ClinicalTrials.gov identifier
Public title Effects of exercise on knee cartilage and bone
Scientific title Controversial effects of exercise on articulate cartilage and bone
Acronym LuRu
Serial number at source 123140
Study hypothesis Osteoarthritis (OA) and osteoporosis (OP) are two common diseases, closely associated with aging, morbidity and disability. The predicted aging of population will accentuate the burden of OA and OP on health care systems. Without population level intervention, the increasing trend is likely to continue thus creating a true public health problem for our societies. Consequently, there is an obvious social need for efficient and cost-effective prevention of bone loss and reduce the impact of arthritis and chronic joint symptoms. Importantly, these actions should be feasible at the population level and that the intervention would not require special resources or expertise from the health care professionals.

Hypothesis:
Physical exercise regimens similar to that used in this trial will decrease the degenerative process of the joint and age related bone loss. Additionally, the exercise regimen improves functional ability and quality of life of the subjects. Further knowledge on the potential relationship of the effects of exercise on osteoarthritis (OA) and osteoporosis (OP) is crucial, because regardless of the causality of OA-OP interaction, it may prevent disability and pain or bone fractures with people suffering from OA or OP.
Ethics approval Ethics Committee of the Central Finland Health Care District. Date of approval: 23/01/2008 (ref: Dnro 1E/2008)
Study design Randomised, controlled, single-centre trial
Countries of recruitment Finland
Disease/condition/study domain Osteoarthritis (OA) and osteoporosis (OP)
Participants - inclusion criteria 1. Voluntary, 52-65 years old postmenopausal women
2. Regular intensive exercise (such as strength or aerobic, impact type of training) no more than two times a week
3. No history of any illness for which exercise is contraindicated or that would limit their participation in the exercise programme
4. Subjects with mild to moderate knee pain during the last 12 months
5. Willingness, and voluntarily signed informed consent to undergo testing and intervention procedures with all of its aspects
6. Weight-bearing knee x-rays show grade 1-2 OA according to Kellgren-Lawrence grade I or II
Participants - exclusion criteria 1. Body-mass index over 34
2. Knee instability or trauma
3. Inflammatory joint disease
4. Intra-articular steroid injections in the preceding 12 months in the knee
5. Osteoporosis and medications
Anticipated start date 17/03/2008
Anticipated end date 30/11/2009
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 80
Interventions The participants will be randomly allocated to the two arms in equal numbers (i.e. 40 each).

Exercise training group:
Supervised aerobic and step-aerobic programme. A qualified trainer will provide supervised training sessions, three times a week for 12 months. Each session lasts 60 minutes. Each workout will include 15 minutes warming-up, 20 minutes multidirectional acceleration, stops, deceleration and turns with music, 15 min calisthenics (body strengthening) and 10 minutes period for cooling-down. The training will be an aerobic programme that has been shown to be osteogenic and that includes accelerating and decelerating forwards and sideways, walking with stops and turns with a music.

Control group:
The control group will pay a social visit to the University once every two months and will otherwise be asked to maintain their pre-study level of physical activity. These visits will be designed to standardise exercise habits and to maintain the control group's interest in the study.
Primary outcome measure(s) The following will be assessed at baseline and 12 months:

Cartilage measurements
Structural changes of the tibiofemoral cartilage will be revealed by magnetic resonance imaging (MRI) at 1.5T magnetic field strength. The combination of two techniques, T2 relaxation time, indexing the collagen component of cartilage, and dGEMRIC, reflective of glycosaminoglycan concentration, and volumetric MRI assessment of cartilage thickness will be used to provide a comprehensive assessment of the cartilage status. T2 mapping and structural analysis of bone will provide MRI parameters sensitive to the properties of bone according our previous studies.

Bone measurements
Peripheral quantitative computed tomography (pQCT) (XCT 2000, Stratec Medizintechnik GmbH) will be performed to measure tibial shaft and distal tibia geometry, bone mass distribution and bone strength.
Dual energy X-ray absorptiometry (DXA) will be performed to assess bone mineral content (BMC) (in grams) and areal bone mineral density (aBMD) (in g/cm^2) at the proximal femur, distal femur and proximal tibia.

In addition, a structural analysis of the narrowest section of the femoral neck will be carried out using a customised bone strength analysis software. Based on our previous study, the quality of subchondral bone will be evaluated with MRI using the T2 relaxation time measurements.
Secondary outcome measure(s) The following will be assessed at baseline, 6 and 12 months:
1. Knee pain will be evaluated by a 100 mm visual analogue scale (VAS) with 0 mm and 100 mm indicating no pain and the worst possible pain, respectively. Pain will be measured before, during and after every training session.
2. Physical function and clinically-important symptoms will be evaluated by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Knee Injury and Osteoarthritis Outcome Score (KOOS). Physical function and symptoms will be correlated with structural changes of cartilage assessed with MRI. This will brings up clinically important information in terms of cartilage alterations association with clinical findings.
3. X-ray (weight-bearing anteroposterior and mediolateral radiographs) will be taken for both knees. The radiographs will be evaluated by two physicians without knowledge in which study arm the subject belongs to, using the criteria for the classification of osteoarthritis of the knee (blinded assessment).
4. Quality of life will be evaluated by the RAND 36-Item Health Survey questionnaire.
5. Muscle strength (leg extension and flexion) will be measured using the David-200 and 210 dynamometers.
6. Dynamic balance and agility will be evaluated with a timed figure-of-eight running test.
7. Physical activity monitoring: Physical activity will be monitored using an accelerometer-based body movement monitor (Newtest Ltd), analysing the activity data at different acceleration levels to evaluate the intensity of exercise according to our procedures.
Sources of funding Academy of Finland (Finland) (ref: 123140)
Trial website
Publications
Contact name Prof  Ari  Heinonen
  Address Department of Health Sciences
University of Finland
  City/town Jyväskylä
  Zip/Postcode 40014
  Country Finland
  Tel +358 14 260 2164
  Fax +358 14 260 2011
  Email ari.heinonen@sport.jyu.fi
Sponsor University of Jyväskylä (Finland)
  Address Seminaarinmäki
Building T
P.O.Box 35
  City/town Jyväskylä
  Zip/Postcode FI-40014
  Country Finland
  Sponsor website: http://www.jyu.fi
Date applied 22/04/2008
Last edited 24/07/2008
Date ISRCTN assigned 24/07/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central